R. Bals (Marburg, Germany), C. Bingle (Sheffield, United Kingdom)
Systemic effects of bronchial colonization in early COPD patients enrolled in the PAC-COPD cohort
A. Marin-Tapia, J. Garcia-Aymerich, E. Monsó, J. Sauleda, F. Gómez, J. Belda, J. M. Antó (Barcelona, Palma de Mallorca, Valencia, Spain)
|  |
Application of omics technologies to the identification of biomarkers for COPD
I. Kilty, R. Walsh, J. Bandow, R. Hidi, G. Johnston, P. Phillips, S. Ward, L. Nagy (Sandwich, United Kingdom; Debrecen, Hungary)
|   |
Interleukin-17 enhances epithelial IL-6 production solely by stabilizing IL-6 mRNA, which is reversed by microRNA16
A. van den Berg, P. Gupta, M. Snoek, R. Lutter (Amsterdam, Netherlands)
| |
Decreased pulmonary mature dendritic cells in healthy smokers and smoking COPD patients
M. Tsoumakidou, I. Bouloukaki, K. Koubidou, H. Koutala, N. Tzanakis, P. Jeffery, N. Siafakas (Crete, Greece)
| |
Treg alterations lead to systemic and local immune deregulation in idiopathic pulmonary fibrosis and collagen vascular disease-associated interstitial pneumonia
E. Nakou, A. Tzouvelekis, I. Bouchliou, G. Kouliatsis, M. Froudarakis, P. Steiropoulos, I. Kotsianidis, D. Bouros (Alexandroupolis, Greece)
| |
Altered expression of TLR4 and of beta defensin 2 in chronic obstructive pulmonary disease
E. Pace, M. Ferraro, M. I. Minervini, P. Vitulo, G. Chiappara, A. M. Montalbano, L. Pipitone, M. Johnson, F. Caronia, G. Bonsignore, B. Gridelli, M. Gjomarkaj (Palermo, Italy; Greenford, Middlesex, United Kingdom)
| |
Adenosine receptor expression in sputum of COPD and asymptomatic smokers, before and one year after smoking cessation
M. Versluis, B. Willemse, D. Postma, M. Geerlings, B. Rutgers, N. Ten Hacken, W. Timens, M. Hylkema (Groningen, Netherlands)
| |
Vasoactive intestinal peptide-receptor regulation in monocytes derived from COPD patients
B. Burian, B. Marzluf, A. Storka, Y. C. Yen, V. Petkov, W. Mosgoeller (Vienna, Austria)
| |